On Wednesday, South Africa resumed its COVID-19 vaccine rollout, two weeks after suspending the Johnson & Johnson vaccine. This time around, the country will have an extra boost of more than 1 million doses, produced locally. The World’s Halima Gikandi reports on what this tells us about vaccine manufacturing in Africa.
The story you just read is accessible and free to all because thousands of listeners and readers contribute to our nonprofit newsroom. We go deep to bring you the human-centered international reporting that you know you can trust. To do this work and to do it well, we rely on the support of our listeners. If you appreciated our coverage this year, if there was a story that made you pause or a song that moved you, would you consider making a gift to sustain our work through 2024 and beyond?